Author

Liping Su

Sichuan University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Haslina AhmadiD· 1 shared Martin R. GilliD· 1 shared Nur Aininie YusohiD· 1 shared Suet Lin ChiaiD· 1 shared Xiaohe TianiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Haslina AhmadORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PARP inhibition enhances exemestane efficacy in triple-negative breast cancer

Nur Aininie Yusoh, Liping Su, Suet Lin Chia, Xiaohe Tian, Haslina Ahmad, Martin R. Gill

This study identifies Exemestane as a synergistic partner for Olaparib in triple-negative breast cancer, enhancing efficacy through DNA damage and apoptosis.

Molecular Oncology · Jul 13, 2025Peer-reviewedPharmacology & Toxicology